Preeclampsia
Conditions
Brief summary
The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Age greater than or equal to 18 years * Women with singleton and twin pregnancies complicated by hypertensive states of pregnancy.
Exclusion criteria
* Minors under 18 years of age. * Women with mental disabilities. * Major congenital fetal anomaly.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prolongation of at least one week of gestation in pregnancy complicated by hypertensive state of pregnancy with antihypertensive therapy guided by hemodynamic phenotypes | Up to 40 weeks | Number of weeks of pregnancy |
Countries
Spain